World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
91
Citations
80865
World Ranking
11479
National Ranking
5883

Overview

Richard H. Grimm is affiliated with the University of Minnesota in the United States. Their research primarily falls within the field of Medicine, with a focus on subfields such as Endocrinology, Diabetes and Metabolism, Surgery, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, and Emergency Medicine.

The research topics covered by Grimm include:

  • Diabetes Treatment and Management
  • Lipoproteins and Cardiovascular Health
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • HIV-related health complications and treatments
  • Aortic Disease and Treatment Approaches
  • Aortic aneurysm repair treatments
  • Infectious Aortic and Vascular Conditions

Grimm's recent papers demonstrate a breadth of investigation within these areas. Notable publications include:

  • "Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials," 2022, published in The Lancet
  • "The modified frozen elephant trunk may outperform limited and extended-classic repair in acute type I dissection," 2023, published in European Journal of Cardio-Thoracic Surgery
  • "Impact of the 2017 American Heart Association and American College of Cardiology hypertension guideline in aged individuals," 2020, published in Journal of Hypertension
  • "Outcomes of Combined Cardiovascular Risk Factor Management Strategies in Type 2 Diabetes: The ACCORD Randomized Trial," 2020, published by UNC Libraries
  • "Nine-Year Effects of 3.7 Years of Intensive Glycemic Control on Cardiovascular Outcomes," 2020, published by UNC Libraries

Frequent coauthors that have appeared alongside Grimm in multiple publications include:

  • Jeffrey L. Probstfield
  • Andrew Tonkin
  • Brian P. Griffin
  • Karen L. Margolis
  • John B. Buse

Grimm has published recurrently in certain academic venues, such as:

  • UNC Libraries
  • The Lancet
  • European Journal of Cardio-Thoracic Surgery
  • Journal of Hypertension
  • Circulation

Best Publications

  • Effects of intensive glucose lowering in type 2 diabetes

    Hertzel C Gerstein;Michael E Miller;Robert P Byington

  • K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification

    Andrew S. Levey;Josef Coresh;Kline Bolton;Bruce Culleton

  • Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)

    Curt D. Furberg;Jackson T. Wright;Barry R Davis;Jeffrey A. Cutler

  • Effects of combination lipid therapy in type 2 diabetes mellitus.

    Henry N. Ginsberg;Laura C. Lovato;Lawrence A. Leiter;Peter Linz

  • The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

    Colin Baigent;Martin J Landray;Christina Reith;Jonathan Emberson

  • K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease

    Shaul G. Massry;Jack W. Coburn;Glenn M. Chertow;Keith Hruska

  • Major Outcomes in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin vs Usual Care

    Curt D. Furberg;Jackson T. Wright;Barry R. Davis;Jeffrey A. Cutler

  • Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial

    Faramarz Ismail-Beigi;Timothy Craven;Mary Ann Banerji;Jan Basile

  • Treatment of Mild Hypertension Study: Final Results

    J D Neaton;R H Grimm;R J Prineas;J Stamler

  • Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

    William C. Cushman;Charles E. Ford;Jeffrey A. Cutler;Karen L. Margolis

  • Feasibility of Treating Prehypertension with an Angiotensin-Receptor Blocker

    Stevo Julius;Shawna D. Nesbitt;Brent M. Egan;Michael A. Weber

  • Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes

    Hertzel C. Gerstein;Michael E. Miller;Saul Genuth;Faramarz Ismail-Beigi

  • K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease

    Andrew S. Levey;Michael V. Rocco;Sharon Anderson;Sharon P. Andreoli

  • Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.

    Henry R. Black;William J. Elliott;Gregory Grandits;Patricia Grambsch

  • Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly

    John J. McNeil;Rory Wolfe;Robyn L. Woods;Andrew M. Tonkin

  • Prevention of Heart Failure by Antihypertensive Drug Treatment in Older Persons With Isolated Systolic Hypertension

    Kostis Jb;Davis Br;Cutler J;Grimm Rh

  • Effect of aspirin on all-cause mortality in the healthy elderly

    John J. McNeil;Mark R. Nelson;Robyn L. Woods;Jessica E. Lockery

  • Rationale and Design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

    Barry R Davis;Jeffrey A. Cutler;David J. Gordon;Curt D. Furberg

  • Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Design and Methods

    John B. Buse

  • Principal results of the controlled onset verapamil investigation of cardiovascular end points (CONVINCE) trial

    H.R. Black;W.J. Elliott;G. Granditis;P. Grambsch

Frequent Co-Authors

James D. Neaton
James D. Neaton University of Minnesota
John M. Flack
John M. Flack Southern Illinois University School of Medicine
Jeremiah Stamler
Jeremiah Stamler Northwestern University
Ronald J. Prineas
Ronald J. Prineas Wake Forest University
Jeffrey A. Cutler
Jeffrey A. Cutler National Institutes of Health
Barry R. Davis
Barry R. Davis The University of Texas Health Science Center at Houston
Karen L. Margolis
Karen L. Margolis HealthPartners
Henry R. Black
Henry R. Black New York University School of Medicine
William C. Cushman
William C. Cushman University of Tennessee Health Science Center
Christopher M. Reid
Christopher M. Reid Monash University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring a future in Medicine in the USA, online degrees can help fast-track your healthcare career. Many students choose to start with online nursing courses for flexibility and foundational knowledge. These programs are ideal for those seeking to learn at their own pace while balancing work or family commitments.

For students who are already Registered Nurses, advancing your credentials is possible with rn to bsn online programs that offer affordability and convenience. If you aim for advanced practice roles, finding the cheapest online fnp program can make becoming a Family Nurse Practitioner accessible.

Those interested in leadership, research, or educational roles in healthcare may pursue doctoral studies. For budget-conscious students, reviewing the cheapest dnp programs is essential to minimize student debt. Choosing the right online pathway depends on your career ambitions, current qualifications, and personal circumstances.

Best Scientists Citing Richard H. Grimm

Trending Scientists